146 related articles for article (PubMed ID: 31682773)
21. Recurrent
Matsuo H; Yoshida K; Fukumura K; Nakatani K; Noguchi Y; Takasaki S; Noura M; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Shiba N; Yamato G; Handa H; Ono Y; Hiramoto N; Ishikawa T; Usuki K; Ishiyama K; Miyawaki S; Itonaga H; Miyazaki Y; Kawamura M; Yamaguchi H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Hayashi Y; Mano H; Miyano S; Kamikubo Y; Ogawa S; Adachi S
Blood Adv; 2018 Nov; 2(21):2879-2889. PubMed ID: 30381403
[TBL] [Abstract][Full Text] [Related]
22. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
23. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H; Nakamura N; Tomizawa D; Saito AM; Kiyokawa N; Horibe K; Nishinaka-Arai Y; Tokumasu M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
Pediatr Blood Cancer; 2016 Aug; 63(8):1394-9. PubMed ID: 27135782
[TBL] [Abstract][Full Text] [Related]
24. Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays.
Mirza MK; Sukhanova M; Stölzel F; Onel K; Larson RA; Stock W; Ehninger G; Kuithan F; Zöphel K; Reddy P; Joseph L; Raca G
Leuk Res; 2014 Sep; 38(9):1091-6. PubMed ID: 25088808
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
Zerkalenkova E; Lebedeva S; Kazakova A; Tsaur G; Starichkova Y; Timofeeva N; Soldatkina O; Aprelova E; Popov A; Ponomareva N; Baidun L; Meyer C; Novichkova G; Maschan M; Maschan A; Marschalek R; Olshanskaya Y
Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
[TBL] [Abstract][Full Text] [Related]
26. Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia.
Chen SM; Silverman DA; Jatana KR; Chiang T; Guinipero T; Hill N; Siu JJ; Reed S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():126-129. PubMed ID: 31005747
[TBL] [Abstract][Full Text] [Related]
27. High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 trial.
Shiba N; Ohki K; Kobayashi T; Hara Y; Yamato G; Tanoshima R; Ichikawa H; Tomizawa D; Park MJ; Shimada A; Sotomatsu M; Arakawa H; Horibe K; Adachi S; Taga T; Tawa A; Hayashi Y
Br J Haematol; 2016 Feb; 172(4):581-91. PubMed ID: 26684393
[TBL] [Abstract][Full Text] [Related]
28. Importance of assessing cytogenetic and molecular risk factors in acute myeloid leukemia therapy.
Coles EC; Colita A; Momanu R; Berbec N; Ivanescu AM; Oprea M; Jardan D; Jardan C; Arghir A; Coriu D; Lupu AR
J Med Life; 2012; 5(Spec Issue):36-43. PubMed ID: 31803284
[TBL] [Abstract][Full Text] [Related]
29. A case of myeloid sarcoma of the mandibular gingiva as extramedullary relapse of acute myeloid leukemia.
Ishikawa S; Kato Y; Kabasawa T; Yoshioka C; Kitabatake K; Yamakawa M; Ishizawa K; Iino M
Oral Maxillofac Surg; 2020 Mar; 24(1):121-126. PubMed ID: 31788742
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821.
Chang M; Raimondi SC; Ravindranath Y; Carroll AJ; Camitta B; Gresik MV; Steuber CP; Weinstein H
Leukemia; 2000 Jul; 14(7):1201-7. PubMed ID: 10914543
[TBL] [Abstract][Full Text] [Related]
31. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML.
Schoch C; Kern W; Schnittger S; Hiddemann W; Haferlach T
Leukemia; 2004 Jan; 18(1):120-5. PubMed ID: 14586477
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
[TBL] [Abstract][Full Text] [Related]
33. Extramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
Støve HK; Sandahl JD; Abrahamsson J; Asdahl PH; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Hasle H
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28333413
[TBL] [Abstract][Full Text] [Related]
34. Myeloid sarcoma.
Shahin OA; Ravandi F
Curr Opin Hematol; 2020 Mar; 27(2):88-94. PubMed ID: 31904666
[TBL] [Abstract][Full Text] [Related]
35. Unrelated donor hematopoietic stem cell transplantation for pediatric de novo acute myeloid leukemia with intermediate- or high-risk cytogenetics.
Park EG; Yi ES; Choi YB; Sung KW; Koo HH; Yoo KH
Pediatr Transplant; 2019 Jun; 23(4):e13397. PubMed ID: 30955250
[TBL] [Abstract][Full Text] [Related]
36. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
37. [Isolated myeloid sarcoma involving the mediastinum].
Jelić-Puskarić B; Kardum-Skelin I; Sustercić D; Pazur M; Vrhovac R; Radić-Kristo D; Gredelj-Simec N; Kovacević DO; Plasćak J; Gasparov S; Jaksić B
Acta Med Croatica; 2011 Sep; 65 Suppl 1():133-8. PubMed ID: 23126041
[TBL] [Abstract][Full Text] [Related]
38. Myeloid sarcoma: A clinicopathological study with emphasis on diagnostic difficulties.
Kudva R; Monappa V; Solanke G; Valiathan M; Rao ACK; Geetha V
J Cancer Res Ther; 2017; 13(6):989-993. PubMed ID: 29237964
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic stem cell transplantation in pediatric patients with acute myeloid leukemia without favorable cytogenetics.
Suh JK; Lee SW; Koh KN; Im HJ; Choi ES; Jang S; Park CJ; Seo JJ
Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28762602
[TBL] [Abstract][Full Text] [Related]
40. Genomic analysis in myeloid sarcoma and comparison with paired acute myeloid leukemia.
Greenland NY; Van Ziffle JA; Liu YC; Qi Z; Prakash S; Wang L
Hum Pathol; 2021 Feb; 108():76-83. PubMed ID: 33232718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
